TIAA CREF INVESTMENT MANAGEMENT LLC - ARRAY BIOPHARMA INC ownership

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 274 filers reported holding ARRAY BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.3%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q1 2019$19,774,000
+74.0%
811,088
+1.7%
0.01%
+55.6%
Q4 2018$11,364,000
-51.8%
797,493
-48.6%
0.01%
+12.5%
Q3 2018$23,596,000
+37.4%
1,552,390
+51.6%
0.01%
-33.3%
Q2 2018$17,179,000
-0.9%
1,023,788
-3.6%
0.01%0.0%
Q1 2018$17,334,000
+63.4%
1,062,155
+28.2%
0.01%
+71.4%
Q4 2017$10,608,000
+13.7%
828,739
+9.2%
0.01%
+16.7%
Q3 2017$9,332,000
+95.6%
758,720
+33.1%
0.01%
+100.0%
Q2 2017$4,772,000
-11.6%
570,182
-5.5%
0.00%
-25.0%
Q1 2017$5,396,000
-18.3%
603,528
-19.7%
0.00%
-20.0%
Q4 2016$6,605,000
+56.7%
751,440
+20.4%
0.01%
+66.7%
Q3 2016$4,214,000
+76.4%
624,244
-7.0%
0.00%
+50.0%
Q2 2016$2,389,000
+24.0%
671,157
+2.7%
0.00%
+100.0%
Q1 2016$1,927,000
+1.4%
653,291
+45.1%
0.00%0.0%
Q4 2015$1,900,000
-10.3%
450,291
-3.0%
0.00%
-50.0%
Q3 2015$2,118,000
-48.7%
464,394
-19.0%
0.00%
-33.3%
Q2 2015$4,132,000
-0.6%
573,116
+1.6%
0.00%0.0%
Q1 2015$4,158,000
+89.5%
564,210
+21.6%
0.00%
+50.0%
Q4 2014$2,194,000
+28.9%
463,916
-2.7%
0.00%
+100.0%
Q3 2014$1,702,000
-24.9%
476,825
-4.1%
0.00%
-50.0%
Q2 2014$2,267,000
+2.3%
497,211
+5.5%
0.00%0.0%
Q1 2014$2,215,000
-7.5%
471,374
-1.4%
0.00%0.0%
Q4 2013$2,395,000
-18.3%
478,094
+1.5%
0.00%0.0%
Q3 2013$2,931,000
+32.4%
471,253
-3.3%
0.00%0.0%
Q2 2013$2,213,000487,4850.00%
Other shareholders
ARRAY BIOPHARMA INC shareholders Q1 2019
NameSharesValueWeighting ↓
Advisory Services Network, LLC 3,442$159,0000.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ARRAY BIOPHARMA INC shareholders